The accreditors of this session require that you periodically check in to verify that you are still attentive.
Please click the button below to indicate that you are.
Sp1288
LEARN ABOUT OMVOH: SOME DISCOVERIES ARE TOO URGENT TO IGNORE
The landscape of treatment for IBD has evolved significantly over the past two decades. This session will examine advances in our understanding of disease pathogenesis and review treatment paradigm changes…
There are multiple new biologic agents that have been approved for the management of IBD over the past few years. In addition, high quality randomized controlled trials have examined optimization of these treatments through therapeutic drug monitoring…